These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 25506830)

  • 1. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
    Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
    PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013).
    Bigna JJ; Noubiap JJ; Agbor AA; Plottel CS; Billong SC; Ayong AP; Koulla-Shiro S
    PLoS One; 2015; 10(7):e0132394. PubMed ID: 26214516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
    Tanue EA; Nsagha DS; Njamen TN; Assob NJC
    PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
    Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
    Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study.
    Ali SA; Mavundla TR; Fantu R; Awoke T
    BMC Infect Dis; 2016 Nov; 16(1):640. PubMed ID: 27814693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for mortality in patients with tuberculosis and HIV in Douala (Cameroon).
    Essomba NE; Ngaba PG; Halle MP; Afane-Voundi Y; Coppieters Y
    Med Sante Trop; 2017 Aug; 27(3):286-291. PubMed ID: 28947405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of tuberculosis and HIV co-infection in Cotonou, Benin.
    Agodokpessi G; Ade G; Ade S; Wachinou AP; Affolabi D; Anagonou S; Gninafon M
    Med Mal Infect; 2012 Nov; 42(11):561-6. PubMed ID: 23044083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
    Sinshaw Y; Alemu S; Fekadu A; Gizachew M
    BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of social determinants on tuberculosis/HIV co-infection mortality in southwest Ethiopia: a retrospective cohort study.
    Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
    BMC Res Notes; 2016 Feb; 9():89. PubMed ID: 26868489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.
    Njozing NB; Miguel SS; Tih PM; Hurtig AK
    BMC Public Health; 2010 Mar; 10():129. PubMed ID: 20226022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
    Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
    Muyaya LM; Musanda EM; Tamuzi JL
    BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Parchure R; Kulkarni V; Gangakhedkar R; Swaminathan S
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1348-1353. PubMed ID: 27725046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria.
    Babatunde OI; Christiandolus EO; Bismarck EC; Emmanuel OI; Chike AC; Gabriel EI
    Afr Health Sci; 2016 Sep; 16(3):655-662. PubMed ID: 27917196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
    Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
    PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.
    Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
    Infect Dis Poverty; 2016 Nov; 5(1):96. PubMed ID: 27802839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.